American Heart Association 
National Cholesterol Education Program, National Institutes of Health, Adult Treatment Panel III Report on High Blood Cholesterol
The National Academy of Clinical Biochemistry, Laboratory Medicine Practice Guidelines, Emerging Biomarkers of Cardiovascular Disease and Stroke

BIBLIOGRAFÍA

S1
Pagana, Kathleen D. & Pagana, Timothy J. (© 2007).  Mosby’s Diagnostic and Laboratory Test Reference 8th Edition:  Mosby, Inc., Saint Louis, MO., Pp 110-114.

S2
Clarke, W. and Dufour, D. R., Editors (2006).  Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC.  Winter, W. and Harris, N. Chapter 21: Lipoprotein Disorders, pp 251-259.

S3
Thomas, Clayton L., Editor (1997).  Taber’s Cyclopedic Medical Dictionary.  F.A. Davis Company, Philadelphia, PA [18th Edition].

S4
Harrison’s Principles of Internal Medicine, 16th edition, Kasper, Braunwald, Fauci, Hauser, Longo, Jameson, eds. McGraw Hill: 2005

S5
(September 1999) The Cleveland Clinic, Center for Continuing Education, Cleveland Clinic Journal of Medicine:  Should One Routinely Screen for Lipoprotein (a)?  (online information, accessed August 2007)
http://clevelandclinicmeded.com/ccjm/sept1999/ccjmoneminutesep99.htm

S6
(September 2006) High Lipoprotein(a) Levels Plus High LDL Increases CVD Risk in Women, Nainggolan L, Medscape Medical News (online information, accessed August 2007)
http://www.medscape.com/viewarticle/544893

S7
Suk Danik J; Rifai N; Buring JE; Ridker PM,  Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.  JAMA.  2006; 296(11):1363-70 (accessed online Sept. 2007)
http://www.medscape.com/medline/abstract/16985228